FDA Information
- Stimulants
- Daytrana Patch - Permanent skin color changes associated with use of Daytrana patch
- Methylphenidate – Rare Risk of Long-Lasting Erections
- SSRIs and Potential Risk for Persistent Pulmonary hypertension of the Newborn
- Celexa-Abnormal Heart Rhythms 8/24/2011
- Anti-Depressants
- Anti-Psychotics
- Aripiprazole – Impulse-control problems
- Clonzapine – Modified Monitoring for Neutropenia, New REMS program
- Olanzapine – Rare but Serious Skin ReactionsZiprasidone (Geodon) – Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
- Ziprasidone (Geodon) – Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
- Zyprexa Relprevv (olanzapine pamoate): Drug Safety Communication
- Mood Stabilizers
- Sleep Medications
FDA Information